Sexual well-being after menopause: An International Menopause Society White Paper

J. A. Simon, S. R. Davis, S. E. Althof, P. Chedraui, A. H. Clayton, S. A. Kingsberg, R. E. Nappi, S. J. Parish, W. Wolfman

Research output: Contribution to journalArticle

Abstract

Sexual well-being frequently declines following the menopause transition and can be associated with significant personal and relationship distress. This distress is the hallmark of female sexual dysfunction (FSD). FSD is highly prevalent in postmenopausal women. The prevalence of sexual problems increases with age, but conversely this is associated with decreasing distress with advancing age. This pattern has been seen across multiple international populations with varied cultural norms. While the etiology of FSD is multifactorial, the physiological changes of sex hormone insufficiency and postmenopausal symptoms, such as dyspareunia, are primary factors contributing to FSD at midlife. The International Menopause Society is working to increase awareness of FSD and to provide a framework for practitioners to address sexual medicine concerns. This White Paper aims to review the process of care for female sexual well-being following menopause, from initially approaching the discussion of FSD, to identifying clinical signs and symptoms, and ultimately determining the best available biopsychosocial therapies. As with most processes of care, the first step is often the most difficult. Health-care practitioners need to broach the topic of sexuality in the clinical setting. Lack of information on, comfort with, and biases about the topic of sexuality after menopause are significant hurdles that the International Menopause Society addresses in this document. Each member of the Writing Group remains committed to continued advocacy for the validity of FSD as a diagnosis, the need for therapies for women to be both available and included in health insurance coverage, and continued therapeutic research to provide evidence-based solutions.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalClimacteric
DOIs
Publication statusAccepted/In press - Jul 9 2018

Fingerprint

Menopause
Sexuality
Therapeutic Human Experimentation
Dyspareunia
Insurance Coverage
Gonadal Steroid Hormones
Health Insurance
Signs and Symptoms
Medicine
Delivery of Health Care
Therapeutics
Population

Keywords

  • female sexual dysfunction
  • female sexual function
  • Menopause

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Simon, J. A., Davis, S. R., Althof, S. E., Chedraui, P., Clayton, A. H., Kingsberg, S. A., ... Wolfman, W. (Accepted/In press). Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric, 1-13. https://doi.org/10.1080/13697137.2018.1482647

Sexual well-being after menopause : An International Menopause Society White Paper. / Simon, J. A.; Davis, S. R.; Althof, S. E.; Chedraui, P.; Clayton, A. H.; Kingsberg, S. A.; Nappi, R. E.; Parish, S. J.; Wolfman, W.

In: Climacteric, 09.07.2018, p. 1-13.

Research output: Contribution to journalArticle

Simon, JA, Davis, SR, Althof, SE, Chedraui, P, Clayton, AH, Kingsberg, SA, Nappi, RE, Parish, SJ & Wolfman, W 2018, 'Sexual well-being after menopause: An International Menopause Society White Paper', Climacteric, pp. 1-13. https://doi.org/10.1080/13697137.2018.1482647
Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA et al. Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric. 2018 Jul 9;1-13. https://doi.org/10.1080/13697137.2018.1482647
Simon, J. A. ; Davis, S. R. ; Althof, S. E. ; Chedraui, P. ; Clayton, A. H. ; Kingsberg, S. A. ; Nappi, R. E. ; Parish, S. J. ; Wolfman, W. / Sexual well-being after menopause : An International Menopause Society White Paper. In: Climacteric. 2018 ; pp. 1-13.
@article{85a4382998e34ab48122d5b654cdcb3b,
title = "Sexual well-being after menopause: An International Menopause Society White Paper",
abstract = "Sexual well-being frequently declines following the menopause transition and can be associated with significant personal and relationship distress. This distress is the hallmark of female sexual dysfunction (FSD). FSD is highly prevalent in postmenopausal women. The prevalence of sexual problems increases with age, but conversely this is associated with decreasing distress with advancing age. This pattern has been seen across multiple international populations with varied cultural norms. While the etiology of FSD is multifactorial, the physiological changes of sex hormone insufficiency and postmenopausal symptoms, such as dyspareunia, are primary factors contributing to FSD at midlife. The International Menopause Society is working to increase awareness of FSD and to provide a framework for practitioners to address sexual medicine concerns. This White Paper aims to review the process of care for female sexual well-being following menopause, from initially approaching the discussion of FSD, to identifying clinical signs and symptoms, and ultimately determining the best available biopsychosocial therapies. As with most processes of care, the first step is often the most difficult. Health-care practitioners need to broach the topic of sexuality in the clinical setting. Lack of information on, comfort with, and biases about the topic of sexuality after menopause are significant hurdles that the International Menopause Society addresses in this document. Each member of the Writing Group remains committed to continued advocacy for the validity of FSD as a diagnosis, the need for therapies for women to be both available and included in health insurance coverage, and continued therapeutic research to provide evidence-based solutions.",
keywords = "female sexual dysfunction, female sexual function, Menopause",
author = "Simon, {J. A.} and Davis, {S. R.} and Althof, {S. E.} and P. Chedraui and Clayton, {A. H.} and Kingsberg, {S. A.} and Nappi, {R. E.} and Parish, {S. J.} and W. Wolfman",
year = "2018",
month = "7",
day = "9",
doi = "10.1080/13697137.2018.1482647",
language = "English",
pages = "1--13",
journal = "Climacteric",
issn = "1369-7137",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Sexual well-being after menopause

T2 - An International Menopause Society White Paper

AU - Simon, J. A.

AU - Davis, S. R.

AU - Althof, S. E.

AU - Chedraui, P.

AU - Clayton, A. H.

AU - Kingsberg, S. A.

AU - Nappi, R. E.

AU - Parish, S. J.

AU - Wolfman, W.

PY - 2018/7/9

Y1 - 2018/7/9

N2 - Sexual well-being frequently declines following the menopause transition and can be associated with significant personal and relationship distress. This distress is the hallmark of female sexual dysfunction (FSD). FSD is highly prevalent in postmenopausal women. The prevalence of sexual problems increases with age, but conversely this is associated with decreasing distress with advancing age. This pattern has been seen across multiple international populations with varied cultural norms. While the etiology of FSD is multifactorial, the physiological changes of sex hormone insufficiency and postmenopausal symptoms, such as dyspareunia, are primary factors contributing to FSD at midlife. The International Menopause Society is working to increase awareness of FSD and to provide a framework for practitioners to address sexual medicine concerns. This White Paper aims to review the process of care for female sexual well-being following menopause, from initially approaching the discussion of FSD, to identifying clinical signs and symptoms, and ultimately determining the best available biopsychosocial therapies. As with most processes of care, the first step is often the most difficult. Health-care practitioners need to broach the topic of sexuality in the clinical setting. Lack of information on, comfort with, and biases about the topic of sexuality after menopause are significant hurdles that the International Menopause Society addresses in this document. Each member of the Writing Group remains committed to continued advocacy for the validity of FSD as a diagnosis, the need for therapies for women to be both available and included in health insurance coverage, and continued therapeutic research to provide evidence-based solutions.

AB - Sexual well-being frequently declines following the menopause transition and can be associated with significant personal and relationship distress. This distress is the hallmark of female sexual dysfunction (FSD). FSD is highly prevalent in postmenopausal women. The prevalence of sexual problems increases with age, but conversely this is associated with decreasing distress with advancing age. This pattern has been seen across multiple international populations with varied cultural norms. While the etiology of FSD is multifactorial, the physiological changes of sex hormone insufficiency and postmenopausal symptoms, such as dyspareunia, are primary factors contributing to FSD at midlife. The International Menopause Society is working to increase awareness of FSD and to provide a framework for practitioners to address sexual medicine concerns. This White Paper aims to review the process of care for female sexual well-being following menopause, from initially approaching the discussion of FSD, to identifying clinical signs and symptoms, and ultimately determining the best available biopsychosocial therapies. As with most processes of care, the first step is often the most difficult. Health-care practitioners need to broach the topic of sexuality in the clinical setting. Lack of information on, comfort with, and biases about the topic of sexuality after menopause are significant hurdles that the International Menopause Society addresses in this document. Each member of the Writing Group remains committed to continued advocacy for the validity of FSD as a diagnosis, the need for therapies for women to be both available and included in health insurance coverage, and continued therapeutic research to provide evidence-based solutions.

KW - female sexual dysfunction

KW - female sexual function

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=85049650346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049650346&partnerID=8YFLogxK

U2 - 10.1080/13697137.2018.1482647

DO - 10.1080/13697137.2018.1482647

M3 - Article

AN - SCOPUS:85049650346

SP - 1

EP - 13

JO - Climacteric

JF - Climacteric

SN - 1369-7137

ER -